Faculty

Institution

Unit

Venue

Ashkan Emadi

Distinguished Professor

West Virginia University

Affiliations

School of Medicine

Cancer Institute

Medical Oncology

Ashkan Emadi is currently serving as a Cancer Institute Distinguished Professor at West Virginia University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Ashkan Emadi

West Virginia University

Distinguished Professor

You can click a keyword to filter the displayed items

medicine oncology hematology pharmacology cancer treatment hematological malignancies medicinal research cancer research pharmacotherapy leukemia cancer care acute myeloid leukemia immunology cancer biology clinical research genetics cancer immunotherapy myeloid neoplasia clinical transplantation medicinal chemistry molecular cancer anti-cancer agents lymphoid neoplasia clinical chemistry enzyme inhibition cellular therapy hemostasis cancer management tumor targeting laboratory medicine cancer genetics immunotherapy respiratory medicine cell therapy cancer genomics drug discovery thrombosis experimental medicine transplantation medicine pharmaceutical practice malignant blood disorders therapeutic efficacy cytogenetics stem cell transplantation redox biology pharmaceutical sciences clinical mycology acute leukemia molecular metabolism cancer growth clinical evidence clinical pharmacy arsenic trioxide adult patients clinical biochemistry cancer risk cell regulation cohort studies pharmaceutical research functional modification treatment options clinical pharmacology clinical outcomes dimeric naphthoquinones acute promyelocytic leukemia aml patients acute lymphoblastic leukemia epigenetic changes clinical case report venous thromboembolism idh mutations clinical response allogeneic transplantation prospective study salvage therapy multiple myeloma gliomas chronic myeloid leukemia brain tumor research cancer discovery mesothelioma cancer drug discovery pathology

Notable Scholarly Works

Notable Federal Grants

Collaborators

Alkynyl Nicotinamides Show Antileukemic Activity in Drug-Resistant Acute Myeloid Leukemia. Journal of Clinical Investigation (2024)

Baskar RamdasNeetu DayalRuchi PandeyElizabeth LarocqueRahul KanumuriSanthosh Kumar PasupuletiSheng LiuChrysi KanellopoulouElizabeth Fei Yin ChuRodrigo MohallemSaniya ViraniGaurav ChopraUma K. AryalRena LapidusJun WanAshkan EmadiLaura S. HanelineFrederick W. HoltsbergM. Javad AmanHerman O. SintimReuben Kapur

alkynyl nicotinamidesclinical medicinepharmacologyantileukemic activityclinical biochemistryhematologyclinical chemistrycancer researchpharmacotherapycancer treatmentclinical investigationneurologyclinical pathologyhematological malignanciesclinical epidemiologyclinical physiologymedicineexperimental medicineclinical researchoncology

Aml-498 Pegcrisantaspase (Pegc) Induces an Increase in Plasma Threonine in Patients With Acute Myeloid Leukemia (Aml). Clinical Lymphoma Myeloma & Leukemia (2024)

Yuchen LiuDominique BollinoErin StrovelRena LapidusFarin KamangarAshkan Emadi

pathologyplasma threoninehematologyleukemiaacute myeloid leukemialymphoid neoplasia

A Phase 1 Study of the Amino Acid Modulator Pegcrisantaspase and Venetoclax for Relapsed/Refractory Acute Myeloid Leukemia. Blood (2024)

Yuchen LiuDominique R BollinoOsman M BahErin T StrovelTien Van LeJinoos ZarrabiSunita PhilipRena G LapidusMaria R BaerSandrine NiyongereVu H. DuongChristine C DoughertyJan Hendrik BeumerKatherine D CaprinoloFarin KamangarAshkan Emadi

malignant blood disordershematological malignancieshematologymedicineleukemiamyeloid neoplasia

Biologic and Clinical Characteristics of Isochromosome Der(17)(Q10)T(15;17) in Acute Promyelocytic Leukemia. Acta Haematologica (2024)

Yuchen LiuYi NingGabriel GhiaurAshkan Emadi

clinical case presentationdermatologyvascular biologytumor biologyhematologyclinical characteristicshaematopoiesismembrane proteinsmedicinal researchmolecular cancerbiochemistryacute promyelocytic leukemiaclinical evidencedisease physiologyimmunohaematologyhepatologyhematological malignanciesmedicineclinical transplantationleukemia

Calaspargase-Pegol-Mknl Combined With Bcl-2 and MCL-1 Inhibition for Acute Myeloid Leukemia. International Journal of Molecular Sciences (2024)

Dominique BollinoXinrong MaKayla M. TigheAndrea CasildoKatharina RichardAntonino PassanitiBrandon Carter-CooperErin T. StrovelAshkan Emadi

oncogenesoncologymolecular medicinehematological malignancieshematologybiochemistrymolecular scienceacute myeloid leukemiamolecular biologytherapeutic efficacyleukemiabiomolecular engineeringmyeloid neoplasia

Clinical Outcomes of Patients With Acute Myeloid Leukemia and Cardiovascular Disease. Leukemia Research (2024)

Gabriela Sanchez-PetittoOlga G. GoloubevaJack MasurJames ChildressTahreem IqbalMax AnSafwan MuhammadJustin LawsonGrace LiBrian BarrAshkan EmadiJennie Y. LawSeung Tae LeeVu H. DuongMaria R. BaerSandrine Niyongere

cardiovascular diseaserespiratory medicinehematologyacute myeloid leukemiamedicineclinical outcomesemergency medicineoncology

Dual Targeting of Glutamine and Serine Metabolism in Acute Myeloid Leukemia. Frontiers in Oncology (2024)

Kanwal M. HameedDominique R. BollinoAmol C. ShettyBrandon Carter-CooperRena G. LapidusAshkan Emadi

serine metabolismredox biologydermatologythoracic oncologycancer researchdual targetingcancer treatmentoncogenesmedicinal researchacute myeloid leukemiafunctional modificationcancer biologyneurologyclinical mycologymolecular medicinehematological malignanciesmembrane biologymedicineenzyme inhibitiononcologyneuro-oncology

Effects of Antioxidant Dietary Supplement Use Upon Response to Cancer Treatment: A Scoping Review of Available Evidence. Nutrition and Cancer (2024)

L. Susan WielandSydney ShadeIlana MoffetAmir AnsariAshkan EmadiCheryl L. KnottEmily F. GormanChristopher R. D’Adamo

health sciencesnutritionavailable evidencecancer treatmentantioxidants

Long-Acting Erwinia Chrysanthemi, Pegcrisantaspase, Induces Alternate Amino Acid Biosynthetic Pathways in a Preclinical Model of Pancreatic Ductal Adenocarcinoma. Cancer & Metabolism (2024)

Dominique BollinoKanwal HameedAnusha BhatArveen ZarrabiAndrea CasildoXinrong MaKayla M TigheBrandon Carter-CooperErin T. StrovelRena G. LapidusAshkan Emadi

pancreatic ductal adenocarcinomapharmacologypreclinical modelenzymestumor biologylong-acting erwinia chrysanthemimolecular biologygene expressionhealth sciencesprotein biosynthesisbiocatalysismolecular cancercancer carecancer biologymolecular metabolismbiotechnologybiochemical sciencescancer growthredox biologycancer genomicsoncology

Long-Term Follow Up of Blinatumomab in Older Patients With B-Cell Acute Lymphoblastic Leukemia. Pharmaceuticals (2024)

Yamini K. KathariMax AnChristine DoughertyAshkan Emadi

epidemiologypharmaceutical practicepharmaceutical sciencescancer immunotherapyolder patientsrespiratory medicinepharmaceuticshematologymedicinepharmacologypharmacotherapylymphoid neoplasiaoncology

1
2
3
4
5
20
10 / page

Ashkan Emadi

Distinguished Professor

West Virginia University

Affiliations

School of Medicine

Cancer Institute

Medical Oncology

Ashkan Emadi is currently serving as a Cancer Institute Distinguished Professor at West Virginia University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Ashkan Emadi

West Virginia University

Distinguished Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Alkynyl Nicotinamides Show Antileukemic Activity in Drug-Resistant Acute Myeloid Leukemia. Journal of Clinical Investigation (2024)

Aml-498 Pegcrisantaspase (Pegc) Induces an Increase in Plasma Threonine in Patients With Acute Myeloid Leukemia (Aml). Clinical Lymphoma Myeloma & Leukemia (2024)

Yuchen LiuDominique BollinoErin StrovelRena LapidusFarin KamangarAshkan Emadi

pathologyplasma threoninehematologyleukemiaacute myeloid leukemialymphoid neoplasia

A Phase 1 Study of the Amino Acid Modulator Pegcrisantaspase and Venetoclax for Relapsed/Refractory Acute Myeloid Leukemia. Blood (2024)

malignant blood disordershematological malignancieshematologymedicineleukemiamyeloid neoplasia

Biologic and Clinical Characteristics of Isochromosome Der(17)(Q10)T(15;17) in Acute Promyelocytic Leukemia. Acta Haematologica (2024)

Yuchen LiuYi NingGabriel GhiaurAshkan Emadi

Calaspargase-Pegol-Mknl Combined With Bcl-2 and MCL-1 Inhibition for Acute Myeloid Leukemia. International Journal of Molecular Sciences (2024)

Dominique BollinoXinrong MaKayla M. TigheAndrea CasildoKatharina RichardAntonino PassanitiBrandon Carter-CooperErin T. StrovelAshkan Emadi

Clinical Outcomes of Patients With Acute Myeloid Leukemia and Cardiovascular Disease. Leukemia Research (2024)

cardiovascular diseaserespiratory medicinehematologyacute myeloid leukemiamedicineclinical outcomesemergency medicineoncology

Dual Targeting of Glutamine and Serine Metabolism in Acute Myeloid Leukemia. Frontiers in Oncology (2024)

Kanwal M. HameedDominique R. BollinoAmol C. ShettyBrandon Carter-CooperRena G. LapidusAshkan Emadi

Effects of Antioxidant Dietary Supplement Use Upon Response to Cancer Treatment: A Scoping Review of Available Evidence. Nutrition and Cancer (2024)

L. Susan WielandSydney ShadeIlana MoffetAmir AnsariAshkan EmadiCheryl L. KnottEmily F. GormanChristopher R. D’Adamo

health sciencesnutritionavailable evidencecancer treatmentantioxidants

Long-Acting Erwinia Chrysanthemi, Pegcrisantaspase, Induces Alternate Amino Acid Biosynthetic Pathways in a Preclinical Model of Pancreatic Ductal Adenocarcinoma. Cancer & Metabolism (2024)

Dominique BollinoKanwal HameedAnusha BhatArveen ZarrabiAndrea CasildoXinrong MaKayla M TigheBrandon Carter-CooperErin T. StrovelRena G. LapidusAshkan Emadi

Long-Term Follow Up of Blinatumomab in Older Patients With B-Cell Acute Lymphoblastic Leukemia. Pharmaceuticals (2024)

Yamini K. KathariMax AnChristine DoughertyAshkan Emadi

epidemiologypharmaceutical practicepharmaceutical sciencescancer immunotherapyolder patientsrespiratory medicinepharmaceuticshematologymedicinepharmacologypharmacotherapylymphoid neoplasiaoncology

1
2
3
4
5
20
10 / page

Similar Faculty Members

Alexander E Perl

Institution

University of Pennsylvania

oncogene

hematological malignancies

Elizabeth Hexner

Institution

University of Pennsylvania

hematology

medicine

Harry Erba

Institution

Duke University

acute leukemia

acute myeloid leukemia

Selina M. Luger

Institution

University of Pennsylvania

hematology

medicine

Yogen Saunthararajah

Institution

Case Western Reserve University

hematological malignancies

hematology

Seongho Kim

Institution

Wayne State University

data analysis

personalized medicine

Peter Greenberg

Institution

Stanford University

hematology

medicine

Christopher R Cogle

Institution

University of Florida

hematology

medicine

Stanton L. Gerson

Institution

Case Western Reserve University

stem cell

haematopoiesis

Stephen J. Schuster

Institution

University of Pennsylvania

oncology

medicine

Similar Faculty Members

Alexander E Perl

Institution

University of Pennsylvania

oncogene

hematological malignancies

Elizabeth Hexner

Institution

University of Pennsylvania

hematology

medicine

Harry Erba

Institution

Duke University

acute leukemia

acute myeloid leukemia

Selina M. Luger

Institution

University of Pennsylvania

hematology

medicine

Yogen Saunthararajah

Institution

Case Western Reserve University

hematological malignancies

hematology

Seongho Kim

Institution

Wayne State University

data analysis

personalized medicine

Peter Greenberg

Institution

Stanford University

hematology

medicine

Christopher R Cogle

Institution

University of Florida

hematology

medicine

Stanton L. Gerson

Institution

Case Western Reserve University

stem cell

haematopoiesis

Stephen J. Schuster

Institution

University of Pennsylvania

oncology

medicine